Swedish Orphan Biovitrum other operating income or expenses for the twelve months ending September 30, 2024 were $0.002B, a 114.16% decline year-over-year.
Swedish Orphan Biovitrum annual other operating income or expenses for 2023 were $-0.01B, a 9996.97% increase from 2022.
Swedish Orphan Biovitrum annual other operating income or expenses for 2022 were $-0B, a 96.46% decline from 2021.
Swedish Orphan Biovitrum annual other operating income or expenses for 2021 were $-0.003B, a 107.19% decline from 2020.
Swedish Orphan Biovitrum Other Operating Income or Expenses 2019-2024 | BIOVF